169 related articles for article (PubMed ID: 19610068)
1. Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer.
Liu J; Ahiekpor A; Li L; Li X; Arbuthnot P; Kew M; Feitelson MA
Int J Cancer; 2009 Oct; 125(8):1894-901. PubMed ID: 19610068
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin.
Lian Z; Liu J; Li L; Li X; Clayton M; Wu MC; Wang HY; Arbuthnot P; Kew M; Fan D; Feitelson MA
Hepatology; 2006 Mar; 43(3):415-24. PubMed ID: 16496348
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis.
Lian Z; Liu J; Wu M; Wang HY; Arbuthnot P; Kew M; Feitelson MA
Hepatology; 2007 Jun; 45(6):1390-9. PubMed ID: 17539024
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma.
Liu J; Lian Z; Han S; Waye MM; Wang H; Wu MC; Wu K; Ding J; Arbuthnot P; Kew M; Fan D; Feitelson MA
Oncogene; 2006 Feb; 25(7):1008-17. PubMed ID: 16247464
[TBL] [Abstract][Full Text] [Related]
5. The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor alpha-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin.
Pan J; Lian Z; Wallet S; Feitelson MA
J Gen Virol; 2007 Dec; 88(Pt 12):3275-3285. PubMed ID: 18024896
[TBL] [Abstract][Full Text] [Related]
6. [Expression of c-erbB-2 protein and EGF receptor in hepatitis B, cirrhosis and hepatocellular carcinoma].
Su Q; Liu Y
Zhonghua Bing Li Xue Za Zhi; 1995 Apr; 24(2):93-5. PubMed ID: 7788735
[TBL] [Abstract][Full Text] [Related]
7. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.
Seo JH; Kim KW; Murakami S; Park BC
J Korean Med Sci; 1997 Dec; 12(6):523-31. PubMed ID: 9443091
[TBL] [Abstract][Full Text] [Related]
8. [The effects of p38MAPK and HBxAg on cell proliferation and apoptosis in human hepatocarcinogenesis].
Shen LJ; Guo W; Gao P; Yu J; Qian ZY; Zhang HX; Zhang ZJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):227-30. PubMed ID: 22475145
[TBL] [Abstract][Full Text] [Related]
9. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.
Feitelson MA; Reis HM; Tufan NL; Sun B; Pan J; Lian Z
Cancer Lett; 2009 Dec; 286(1):69-79. PubMed ID: 19201080
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.
Harada K; Shiota G; Kawasaki H
Liver; 1999 Aug; 19(4):318-25. PubMed ID: 10459631
[TBL] [Abstract][Full Text] [Related]
11. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.
Hu BS; Xiong SM; Li G; Li JP
Tumour Biol; 2016 Oct; 37(10):13445-13453. PubMed ID: 27465549
[TBL] [Abstract][Full Text] [Related]
13. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin.
Pan J; Clayton M; Feitelson MA
J Gen Virol; 2004 Feb; 85(Pt 2):275-282. PubMed ID: 14769885
[TBL] [Abstract][Full Text] [Related]
15. Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence.
Shi JH; Guo WZ; Jin Y; Zhang HP; Pang C; Li J; Line PD; Zhang SJ
Cancer Med; 2019 Mar; 8(3):1269-1278. PubMed ID: 30714677
[TBL] [Abstract][Full Text] [Related]
16. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma.
Wang B; Tang J; Liao D; Wang G; Zhang M; Sang Y; Cao J; Wu Y; Zhang R; Li S; Ding W; Zhang G; Kang T
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S684-92. PubMed ID: 23943028
[TBL] [Abstract][Full Text] [Related]
17. A cellular gene up-regulated by hepatitis B virus-encoded X antigen promotes hepatocellular growth and survival.
Lian Z; Liu J; Pan J; Satiroglu Tufan NL; Zhu M; Arbuthnot P; Kew M; Clayton MM; Feitelson MA
Hepatology; 2001 Jul; 34(1):146-57. PubMed ID: 11431746
[TBL] [Abstract][Full Text] [Related]
18. Human S15a expression is upregulated by hepatitis B virus X protein.
Lian Z; Liu J; Li L; Li X; Tufan NL; Wu MC; Wang HY; Arbuthnot P; Kew M; Feitelson MA
Mol Carcinog; 2004 May; 40(1):34-46. PubMed ID: 15108328
[TBL] [Abstract][Full Text] [Related]
19. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
[TBL] [Abstract][Full Text] [Related]
20. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
